In January 2004, Major League Baseball announced a new drug policy which originally included random, offseason testing and 10-day suspensions for first-time offenders, 30-days for second-time offenders, 60-days for third-time offenders, and one year for fourth-time offenders, all without pay, in an effort to curtail performance-enhancing drug use (PED) in professional baseball. This policy strengthened baseball's pre-existing ban on controlled substances , including steroids, which has been in effect since 1991.  The policy was to be reviewed in 2008, but under pressure from the . Congress , on November 15, 2005, players and owners agreed to tougher penalties; a 50-game suspension for a first offense, a 100-game suspension for a second, and a lifetime ban for a third.
Pharmacom Labs PHARMA Nan D300 is presented in a 10ml vial and reportedly contains 300 milligrams of nandrolone decanoate per milliliter according to the label and packaging. Samples of this product were purchased from a European-based authorized reseller and internet source between the dates of April 10, 2015 and May 10, 2015. The samples were forwarded and received by the analytical laboratory Simec AG for HPLC-UV testing on May 19, 2015. The quantitative dosage testing report was completed on June 2, 2015. The “quality code” listed on the product was “zpgtek35de”. The quality code was successfully used to authenticate/verify the product on /code.